Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chromosomes, Human, Y | 14 | 2020 | 164 | 2.720 |
Why?
|
Lebanon | 40 | 2024 | 245 | 2.650 |
Why?
|
Genetics, Population | 23 | 2024 | 944 | 2.280 |
Why?
|
Haplotypes | 25 | 2024 | 2725 | 2.230 |
Why?
|
Gene Flow | 8 | 2024 | 79 | 1.810 |
Why?
|
Coronary Artery Disease | 20 | 2024 | 6569 | 1.460 |
Why?
|
DNA, Mitochondrial | 10 | 2018 | 871 | 1.430 |
Why?
|
Polymorphism, Single Nucleotide | 33 | 2024 | 16051 | 1.390 |
Why?
|
Coronary Stenosis | 4 | 2023 | 802 | 1.320 |
Why?
|
Emigration and Immigration | 7 | 2018 | 407 | 1.240 |
Why?
|
Cholesterol, HDL | 7 | 2024 | 1820 | 1.120 |
Why?
|
Genetic Predisposition to Disease | 20 | 2024 | 18065 | 1.060 |
Why?
|
Apolipoprotein C-I | 1 | 2024 | 14 | 0.960 |
Why?
|
Population | 3 | 2020 | 141 | 0.920 |
Why?
|
Diabetes Mellitus, Type 2 | 12 | 2024 | 12252 | 0.830 |
Why?
|
Globins | 4 | 2005 | 405 | 0.830 |
Why?
|
Refugees | 2 | 2023 | 615 | 0.790 |
Why?
|
Plasma | 3 | 2020 | 585 | 0.770 |
Why?
|
Genome-Wide Association Study | 13 | 2024 | 12798 | 0.740 |
Why?
|
Genetic Variation | 19 | 2019 | 6610 | 0.730 |
Why?
|
Genome, Mitochondrial | 2 | 2018 | 68 | 0.730 |
Why?
|
History, Ancient | 11 | 2019 | 213 | 0.710 |
Why?
|
Transcription Factor 7-Like 2 Protein | 2 | 2023 | 153 | 0.680 |
Why?
|
Urine | 1 | 2020 | 362 | 0.640 |
Why?
|
Sphingomyelins | 1 | 2019 | 105 | 0.620 |
Why?
|
beta-Thalassemia | 4 | 2005 | 236 | 0.610 |
Why?
|
Diabetes Mellitus, Type 1 | 10 | 2013 | 3447 | 0.590 |
Why?
|
Population Dynamics | 5 | 2018 | 314 | 0.520 |
Why?
|
Protein Kinase C-alpha | 1 | 2016 | 113 | 0.520 |
Why?
|
Women | 1 | 2018 | 225 | 0.520 |
Why?
|
Consanguinity | 6 | 2013 | 460 | 0.500 |
Why?
|
Phylogeny | 9 | 2018 | 2843 | 0.480 |
Why?
|
Metabolomics | 6 | 2020 | 1675 | 0.480 |
Why?
|
Alleles | 9 | 2024 | 6901 | 0.470 |
Why?
|
Cyclin-Dependent Kinase 5 | 1 | 2014 | 110 | 0.450 |
Why?
|
Demography | 1 | 2018 | 1643 | 0.420 |
Why?
|
Genome, Human | 11 | 2019 | 4456 | 0.400 |
Why?
|
Phylogeography | 6 | 2019 | 72 | 0.400 |
Why?
|
Respiratory Sounds | 1 | 2016 | 702 | 0.390 |
Why?
|
Syria | 4 | 2023 | 86 | 0.390 |
Why?
|
Genotype | 16 | 2024 | 13048 | 0.360 |
Why?
|
Aortic Valve | 1 | 2020 | 1969 | 0.360 |
Why?
|
Peptidyl-Dipeptidase A | 2 | 2010 | 325 | 0.350 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2016 | 4356 | 0.350 |
Why?
|
Evolution, Molecular | 6 | 2020 | 1894 | 0.350 |
Why?
|
Humans | 121 | 2024 | 768887 | 0.340 |
Why?
|
Polymorphism, Genetic | 7 | 2021 | 4251 | 0.330 |
Why?
|
Cholesterol | 1 | 2019 | 2913 | 0.330 |
Why?
|
Risk Factors | 31 | 2024 | 74971 | 0.330 |
Why?
|
Lipoprotein(a) | 2 | 2023 | 490 | 0.320 |
Why?
|
Acculturation | 1 | 2010 | 179 | 0.320 |
Why?
|
Gas Chromatography-Mass Spectrometry | 2 | 2020 | 354 | 0.320 |
Why?
|
Gene Frequency | 11 | 2017 | 3625 | 0.320 |
Why?
|
Male | 69 | 2024 | 365249 | 0.320 |
Why?
|
Ectodysplasins | 1 | 2008 | 12 | 0.320 |
Why?
|
Middle East | 7 | 2016 | 233 | 0.310 |
Why?
|
Drug Resistance, Viral | 1 | 2014 | 869 | 0.310 |
Why?
|
RNA, Viral | 4 | 2014 | 2871 | 0.310 |
Why?
|
Anemia, Sickle Cell | 2 | 2010 | 1065 | 0.310 |
Why?
|
Communicable Diseases | 1 | 2016 | 873 | 0.300 |
Why?
|
Aortic Valve Stenosis | 1 | 2020 | 2034 | 0.300 |
Why?
|
Polymerase Chain Reaction | 7 | 2007 | 6085 | 0.300 |
Why?
|
Constriction, Pathologic | 4 | 2023 | 1104 | 0.290 |
Why?
|
Principal Component Analysis | 5 | 2024 | 948 | 0.290 |
Why?
|
Ectodermal Dysplasia | 1 | 2008 | 107 | 0.290 |
Why?
|
Hypertension | 4 | 2024 | 8615 | 0.280 |
Why?
|
Genetic Association Studies | 3 | 2017 | 2747 | 0.280 |
Why?
|
Archaeology | 2 | 2018 | 38 | 0.270 |
Why?
|
Pedigree | 4 | 2020 | 4545 | 0.270 |
Why?
|
Genetic Loci | 3 | 2023 | 2630 | 0.260 |
Why?
|
Case-Control Studies | 9 | 2024 | 22294 | 0.260 |
Why?
|
Greece | 2 | 2024 | 340 | 0.250 |
Why?
|
Codon | 2 | 2008 | 599 | 0.250 |
Why?
|
Microsatellite Repeats | 5 | 2020 | 785 | 0.250 |
Why?
|
Arabia | 1 | 2024 | 6 | 0.250 |
Why?
|
Yemen | 1 | 2024 | 10 | 0.250 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2023 | 4642 | 0.250 |
Why?
|
Middle Aged | 35 | 2024 | 223740 | 0.250 |
Why?
|
Proteobacteria | 1 | 2005 | 47 | 0.240 |
Why?
|
Female | 54 | 2024 | 397464 | 0.240 |
Why?
|
Turkey | 2 | 2024 | 256 | 0.240 |
Why?
|
Gene Pool | 4 | 2019 | 36 | 0.230 |
Why?
|
Phenotype | 11 | 2021 | 16735 | 0.230 |
Why?
|
Microfilament Proteins | 2 | 2024 | 1135 | 0.230 |
Why?
|
Water Microbiology | 1 | 2005 | 117 | 0.230 |
Why?
|
Anti-Retroviral Agents | 1 | 2014 | 1794 | 0.230 |
Why?
|
Qb-SNARE Proteins | 1 | 2023 | 34 | 0.230 |
Why?
|
Genetic Testing | 4 | 2006 | 3590 | 0.220 |
Why?
|
DNA, Ribosomal | 1 | 2005 | 300 | 0.220 |
Why?
|
Water Supply | 1 | 2005 | 204 | 0.220 |
Why?
|
Mutation, Missense | 2 | 2014 | 2592 | 0.220 |
Why?
|
Linkage Disequilibrium | 3 | 2024 | 1998 | 0.220 |
Why?
|
Fetal Hemoglobin | 2 | 2003 | 346 | 0.220 |
Why?
|
Chromosome Disorders | 1 | 2006 | 499 | 0.210 |
Why?
|
Seafood | 1 | 2006 | 395 | 0.210 |
Why?
|
Coronary Angiography | 4 | 2023 | 4541 | 0.210 |
Why?
|
Africa, Northern | 6 | 2019 | 86 | 0.200 |
Why?
|
Thalassemia | 1 | 2003 | 267 | 0.200 |
Why?
|
Hepatocyte Nuclear Factor 6 | 1 | 2021 | 10 | 0.200 |
Why?
|
Odds Ratio | 6 | 2021 | 9682 | 0.190 |
Why?
|
China | 6 | 2022 | 2395 | 0.190 |
Why?
|
Adult | 39 | 2024 | 223818 | 0.190 |
Why?
|
Antigens, Differentiation | 1 | 2004 | 921 | 0.190 |
Why?
|
Genetic Heterogeneity | 1 | 2005 | 737 | 0.180 |
Why?
|
Geography | 5 | 2015 | 654 | 0.180 |
Why?
|
Mediterranean Region | 2 | 2018 | 47 | 0.180 |
Why?
|
Aged | 26 | 2024 | 171790 | 0.180 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2021 | 118 | 0.180 |
Why?
|
Mutation | 9 | 2013 | 30266 | 0.180 |
Why?
|
Fruit | 1 | 2006 | 1165 | 0.180 |
Why?
|
Nicotine | 1 | 2005 | 681 | 0.180 |
Why?
|
Spain | 2 | 2019 | 485 | 0.180 |
Why?
|
Africa | 5 | 2019 | 726 | 0.180 |
Why?
|
Hepacivirus | 1 | 2007 | 1344 | 0.180 |
Why?
|
Cresols | 1 | 2020 | 26 | 0.170 |
Why?
|
Promoter Regions, Genetic | 4 | 2014 | 5801 | 0.170 |
Why?
|
Vascular System Injuries | 1 | 2023 | 248 | 0.170 |
Why?
|
Coronary Restenosis | 1 | 2023 | 396 | 0.170 |
Why?
|
DNA, Bacterial | 1 | 2005 | 1478 | 0.170 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2006 | 2525 | 0.170 |
Why?
|
Nepovirus | 2 | 1996 | 2 | 0.170 |
Why?
|
Rural Population | 4 | 2022 | 2322 | 0.160 |
Why?
|
Europe | 10 | 2017 | 3441 | 0.160 |
Why?
|
Population Density | 3 | 2019 | 193 | 0.160 |
Why?
|
Cultural Characteristics | 1 | 2020 | 250 | 0.160 |
Why?
|
Asthma | 2 | 2016 | 6293 | 0.160 |
Why?
|
Genetic Linkage | 5 | 2017 | 2342 | 0.160 |
Why?
|
Smoking | 3 | 2017 | 9094 | 0.160 |
Why?
|
Tumor Virus Infections | 1 | 2002 | 437 | 0.160 |
Why?
|
Delivery of Health Care | 1 | 2016 | 5375 | 0.160 |
Why?
|
Blood Glucose | 3 | 2020 | 6434 | 0.150 |
Why?
|
Urinalysis | 1 | 2020 | 370 | 0.150 |
Why?
|
Bible | 1 | 2018 | 5 | 0.150 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 3 | 2012 | 276 | 0.150 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2002 | 392 | 0.150 |
Why?
|
Italy | 2 | 2018 | 855 | 0.150 |
Why?
|
Age of Onset | 5 | 2013 | 3346 | 0.150 |
Why?
|
Asia | 6 | 2017 | 629 | 0.140 |
Why?
|
Influenza in Birds | 1 | 2018 | 76 | 0.140 |
Why?
|
Hepatitis C | 1 | 2007 | 1595 | 0.140 |
Why?
|
Leptin | 2 | 2002 | 1597 | 0.140 |
Why?
|
Exons | 3 | 2008 | 2395 | 0.140 |
Why?
|
Chromosomes, Human, X | 2 | 2016 | 321 | 0.140 |
Why?
|
Influenza A Virus, H5N1 Subtype | 1 | 2018 | 117 | 0.140 |
Why?
|
Adolescent | 15 | 2019 | 89247 | 0.140 |
Why?
|
Prenatal Diagnosis | 1 | 2004 | 1274 | 0.140 |
Why?
|
Recombination, Genetic | 2 | 2011 | 1526 | 0.140 |
Why?
|
Medical Records | 1 | 2002 | 1411 | 0.140 |
Why?
|
Tunisia | 1 | 2016 | 36 | 0.140 |
Why?
|
Influenza, Human | 2 | 2018 | 1541 | 0.130 |
Why?
|
Myocardial Infarction | 1 | 2017 | 11521 | 0.130 |
Why?
|
Osteoporosis | 2 | 2022 | 1606 | 0.130 |
Why?
|
Cyprus | 1 | 2016 | 96 | 0.130 |
Why?
|
Periodontitis | 1 | 2021 | 577 | 0.130 |
Why?
|
Thromboembolism | 1 | 2003 | 1004 | 0.130 |
Why?
|
Factor V | 2 | 2010 | 168 | 0.130 |
Why?
|
HIV-1 | 1 | 2014 | 6963 | 0.130 |
Why?
|
Tooth | 1 | 2018 | 210 | 0.130 |
Why?
|
Cytochrome P-450 CYP1A2 | 1 | 2015 | 68 | 0.130 |
Why?
|
Viral Core Proteins | 1 | 1996 | 158 | 0.130 |
Why?
|
Sentinel Surveillance | 1 | 2018 | 292 | 0.130 |
Why?
|
HLA-DQ Antigens | 3 | 2009 | 190 | 0.130 |
Why?
|
Chickens | 1 | 2018 | 845 | 0.130 |
Why?
|
Africa South of the Sahara | 3 | 2019 | 752 | 0.130 |
Why?
|
Lipoproteins, LDL | 1 | 2019 | 643 | 0.130 |
Why?
|
Papillomaviridae | 1 | 2002 | 1140 | 0.130 |
Why?
|
Bone Density | 2 | 2022 | 3573 | 0.130 |
Why?
|
Dyslipidemias | 1 | 2023 | 873 | 0.120 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2021 | 1124 | 0.120 |
Why?
|
Prevalence | 7 | 2014 | 15875 | 0.120 |
Why?
|
tRNA Methyltransferases | 1 | 2014 | 50 | 0.120 |
Why?
|
Pancreas | 1 | 2021 | 1700 | 0.120 |
Why?
|
Arabs | 1 | 2017 | 190 | 0.120 |
Why?
|
Polymorphism, Restriction Fragment Length | 3 | 2005 | 767 | 0.120 |
Why?
|
Cholesterol, LDL | 3 | 2019 | 2402 | 0.120 |
Why?
|
Lipoproteins, HDL | 1 | 2019 | 682 | 0.110 |
Why?
|
Reverse Transcription | 1 | 2014 | 48 | 0.110 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 2 | 2007 | 168 | 0.110 |
Why?
|
HIV Protease | 1 | 2014 | 98 | 0.110 |
Why?
|
Amyloidosis, Familial | 1 | 2013 | 16 | 0.110 |
Why?
|
Culture | 1 | 2018 | 623 | 0.110 |
Why?
|
Diabetes Mellitus | 2 | 2023 | 5892 | 0.110 |
Why?
|
Bioartificial Organs | 1 | 2013 | 47 | 0.110 |
Why?
|
Alstrom Syndrome | 1 | 2013 | 11 | 0.110 |
Why?
|
Cultural Evolution | 1 | 2013 | 9 | 0.110 |
Why?
|
Cluster Analysis | 4 | 2016 | 2730 | 0.110 |
Why?
|
HIV Reverse Transcriptase | 1 | 2014 | 214 | 0.110 |
Why?
|
Hyperglycemia | 1 | 2021 | 1389 | 0.100 |
Why?
|
Base Sequence | 7 | 2017 | 12430 | 0.100 |
Why?
|
Sequence Analysis, DNA | 4 | 2014 | 4784 | 0.100 |
Why?
|
Corneal Dystrophies, Hereditary | 1 | 2013 | 62 | 0.100 |
Why?
|
Regression Analysis | 2 | 2020 | 6346 | 0.100 |
Why?
|
Chi-Square Distribution | 3 | 2010 | 3438 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2014 | 362 | 0.100 |
Why?
|
Heart Valve Prosthesis | 1 | 2020 | 1468 | 0.100 |
Why?
|
Mass Spectrometry | 1 | 2019 | 2204 | 0.090 |
Why?
|
Membrane Proteins | 1 | 2008 | 7885 | 0.090 |
Why?
|
Hyperhomocysteinemia | 1 | 2012 | 118 | 0.090 |
Why?
|
Young Adult | 10 | 2021 | 60110 | 0.090 |
Why?
|
Caffeine | 1 | 2015 | 703 | 0.090 |
Why?
|
Genetic Markers | 2 | 2008 | 2604 | 0.090 |
Why?
|
Genes, Transgenic, Suicide | 1 | 2010 | 34 | 0.090 |
Why?
|
Interferon-alpha | 2 | 2007 | 910 | 0.090 |
Why?
|
Biological Evolution | 2 | 2015 | 1078 | 0.090 |
Why?
|
Fertility Agents, Female | 1 | 2010 | 101 | 0.090 |
Why?
|
Respiratory Tract Infections | 1 | 2018 | 1014 | 0.090 |
Why?
|
Mortality | 1 | 2021 | 2915 | 0.090 |
Why?
|
Inflammation | 2 | 2023 | 10869 | 0.080 |
Why?
|
Milk | 2 | 2003 | 440 | 0.080 |
Why?
|
Papillomavirus Infections | 1 | 2002 | 1640 | 0.080 |
Why?
|
Population Groups | 1 | 2010 | 208 | 0.080 |
Why?
|
Cost of Illness | 2 | 2018 | 1959 | 0.080 |
Why?
|
Severity of Illness Index | 3 | 2021 | 15955 | 0.080 |
Why?
|
Infection Control | 1 | 2016 | 984 | 0.080 |
Why?
|
Chromosome Mapping | 2 | 2015 | 4624 | 0.080 |
Why?
|
Tandem Repeat Sequences | 2 | 2009 | 183 | 0.080 |
Why?
|
Mediterranean Sea | 1 | 2008 | 13 | 0.080 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2010 | 279 | 0.080 |
Why?
|
Stroke | 2 | 2022 | 9756 | 0.080 |
Why?
|
Prosthesis Implantation | 1 | 2013 | 594 | 0.080 |
Why?
|
Wolfram Syndrome | 1 | 2008 | 14 | 0.080 |
Why?
|
Child | 11 | 2018 | 80969 | 0.080 |
Why?
|
Homocysteine | 1 | 2012 | 637 | 0.080 |
Why?
|
Body Height | 1 | 2015 | 1568 | 0.080 |
Why?
|
Child, Preschool | 8 | 2018 | 42684 | 0.080 |
Why?
|
Protein Isoforms | 1 | 2013 | 1714 | 0.080 |
Why?
|
Disease Outbreaks | 1 | 2018 | 1761 | 0.080 |
Why?
|
Streptococcus agalactiae | 1 | 2010 | 337 | 0.080 |
Why?
|
Cohort Studies | 6 | 2022 | 41800 | 0.080 |
Why?
|
Diet | 1 | 2006 | 8090 | 0.070 |
Why?
|
Echocardiography | 1 | 2020 | 5046 | 0.070 |
Why?
|
Health Services Needs and Demand | 1 | 2016 | 1407 | 0.070 |
Why?
|
Drug Costs | 1 | 2016 | 1198 | 0.070 |
Why?
|
Behcet Syndrome | 1 | 2008 | 86 | 0.070 |
Why?
|
Brucellosis | 1 | 2007 | 21 | 0.070 |
Why?
|
Histocytological Preparation Techniques | 1 | 2007 | 33 | 0.070 |
Why?
|
Cross-Sectional Studies | 7 | 2020 | 26384 | 0.070 |
Why?
|
HIV Infections | 1 | 2014 | 17589 | 0.070 |
Why?
|
Biotinidase Deficiency | 1 | 2006 | 3 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 1996 | 1891 | 0.070 |
Why?
|
Multivariate Analysis | 1 | 2020 | 12093 | 0.070 |
Why?
|
Isotretinoin | 1 | 2008 | 134 | 0.070 |
Why?
|
HTLV-I Infections | 1 | 2007 | 104 | 0.070 |
Why?
|
B-Lymphocytes | 1 | 2020 | 4794 | 0.070 |
Why?
|
Glomerulonephritis, IGA | 1 | 2006 | 61 | 0.070 |
Why?
|
Microbiological Techniques | 1 | 2007 | 97 | 0.070 |
Why?
|
Human T-lymphotropic virus 1 | 1 | 2007 | 143 | 0.070 |
Why?
|
Heterozygote | 3 | 2016 | 2798 | 0.070 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2010 | 503 | 0.060 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2006 | 229 | 0.060 |
Why?
|
Antigens, CD | 2 | 2008 | 4032 | 0.060 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2006 | 192 | 0.060 |
Why?
|
Language | 2 | 2015 | 1559 | 0.060 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2006 | 247 | 0.060 |
Why?
|
Logistic Models | 4 | 2016 | 13317 | 0.060 |
Why?
|
Albinism, Oculocutaneous | 1 | 2005 | 19 | 0.060 |
Why?
|
Streptococcal Infections | 1 | 2010 | 619 | 0.060 |
Why?
|
Monophenol Monooxygenase | 1 | 2005 | 72 | 0.060 |
Why?
|
Proviruses | 1 | 2007 | 320 | 0.060 |
Why?
|
Cotinine | 1 | 2005 | 206 | 0.060 |
Why?
|
Risk Assessment | 4 | 2016 | 24330 | 0.060 |
Why?
|
Zidovudine | 1 | 2007 | 625 | 0.060 |
Why?
|
Algorithms | 3 | 2019 | 14199 | 0.060 |
Why?
|
Quantitative Trait Loci | 1 | 2012 | 2133 | 0.060 |
Why?
|
Insurance Coverage | 1 | 2016 | 1946 | 0.060 |
Why?
|
Dermatologic Agents | 1 | 2008 | 313 | 0.060 |
Why?
|
Infant | 6 | 2021 | 36541 | 0.060 |
Why?
|
NF-kappa B | 2 | 2010 | 2492 | 0.060 |
Why?
|
Iran | 3 | 2015 | 763 | 0.060 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2005 | 1057 | 0.060 |
Why?
|
Ethiopia | 2 | 2016 | 483 | 0.060 |
Why?
|
Oligonucleotide Probes | 1 | 2004 | 417 | 0.060 |
Why?
|
Depression | 1 | 2023 | 8240 | 0.050 |
Why?
|
Hemoglobin A2 | 1 | 2003 | 6 | 0.050 |
Why?
|
Blood Protein Electrophoresis | 1 | 2003 | 65 | 0.050 |
Why?
|
Family Health | 2 | 2010 | 1255 | 0.050 |
Why?
|
Health Expenditures | 1 | 2016 | 2396 | 0.050 |
Why?
|
Hemoglobin A | 1 | 2003 | 84 | 0.050 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2023 | 179 | 0.050 |
Why?
|
Birth Order | 1 | 2003 | 94 | 0.050 |
Why?
|
Spasms, Infantile | 1 | 2006 | 301 | 0.050 |
Why?
|
Health Personnel | 1 | 2016 | 3382 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 4593 | 0.050 |
Why?
|
alpha-Thalassemia | 1 | 2003 | 53 | 0.050 |
Why?
|
Health | 1 | 2005 | 398 | 0.050 |
Why?
|
Homozygote | 2 | 2004 | 1779 | 0.050 |
Why?
|
Arsenicals | 1 | 2003 | 117 | 0.050 |
Why?
|
Coronary Disease | 1 | 2017 | 5919 | 0.050 |
Why?
|
Syndrome | 1 | 2008 | 3274 | 0.050 |
Why?
|
Hypereosinophilic Syndrome | 1 | 2003 | 97 | 0.050 |
Why?
|
Receptors, CCR5 | 1 | 2004 | 491 | 0.050 |
Why?
|
Molecular Sequence Data | 4 | 2015 | 17629 | 0.050 |
Why?
|
Streptozocin | 1 | 2021 | 190 | 0.050 |
Why?
|
Anthropometry | 1 | 2006 | 1343 | 0.050 |
Why?
|
Point Mutation | 1 | 2006 | 1595 | 0.050 |
Why?
|
Drinking | 1 | 2002 | 196 | 0.050 |
Why?
|
Oxides | 1 | 2003 | 403 | 0.050 |
Why?
|
Aspartate Aminotransferases | 1 | 2022 | 414 | 0.050 |
Why?
|
Aged, 80 and over | 4 | 2019 | 59738 | 0.050 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2005 | 1048 | 0.050 |
Why?
|
Species Specificity | 1 | 2005 | 2419 | 0.040 |
Why?
|
Models, Genetic | 3 | 2017 | 3446 | 0.040 |
Why?
|
Antiviral Agents | 2 | 2018 | 3069 | 0.040 |
Why?
|
Y Chromosome | 1 | 2001 | 205 | 0.040 |
Why?
|
Graft Rejection | 1 | 2013 | 4492 | 0.040 |
Why?
|
Organogenesis | 1 | 2021 | 214 | 0.040 |
Why?
|
Mutagenesis, Insertional | 1 | 2003 | 662 | 0.040 |
Why?
|
Gallbladder | 1 | 2021 | 308 | 0.040 |
Why?
|
Absorptiometry, Photon | 1 | 2006 | 1757 | 0.040 |
Why?
|
Comorbidity | 1 | 2014 | 10591 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2005 | 15662 | 0.040 |
Why?
|
Autoantibodies | 1 | 2008 | 2126 | 0.040 |
Why?
|
Multigene Family | 1 | 2003 | 1082 | 0.040 |
Why?
|
Fossils | 1 | 2019 | 76 | 0.040 |
Why?
|
Obesity | 2 | 2020 | 13087 | 0.040 |
Why?
|
Pancreatic Diseases | 1 | 2021 | 353 | 0.040 |
Why?
|
Animals | 9 | 2023 | 169408 | 0.040 |
Why?
|
Fasting | 1 | 2005 | 1610 | 0.040 |
Why?
|
Fabaceae | 2 | 1996 | 103 | 0.040 |
Why?
|
Vaginal Smears | 1 | 2002 | 505 | 0.040 |
Why?
|
Nutrition Surveys | 1 | 2006 | 1738 | 0.040 |
Why?
|
Plants, Medicinal | 2 | 1996 | 167 | 0.040 |
Why?
|
Body Mass Index | 3 | 2021 | 13054 | 0.040 |
Why?
|
Premature Birth | 1 | 2010 | 1814 | 0.040 |
Why?
|
Proteins | 1 | 2013 | 6011 | 0.040 |
Why?
|
Sex Distribution | 1 | 2003 | 2280 | 0.040 |
Why?
|
Hospitalization | 1 | 2018 | 10845 | 0.040 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2010 | 2183 | 0.040 |
Why?
|
Influenza A Virus, H3N2 Subtype | 1 | 2018 | 85 | 0.040 |
Why?
|
Oseltamivir | 1 | 2018 | 75 | 0.040 |
Why?
|
Triglycerides | 2 | 2015 | 2464 | 0.040 |
Why?
|
Vitamin B 12 | 1 | 2020 | 528 | 0.040 |
Why?
|
Fetal Growth Retardation | 1 | 2021 | 590 | 0.040 |
Why?
|
Chad | 1 | 2016 | 9 | 0.040 |
Why?
|
Reproducibility of Results | 3 | 2017 | 20244 | 0.030 |
Why?
|
Seasons | 1 | 2003 | 1523 | 0.030 |
Why?
|
Morbidity | 1 | 2022 | 1757 | 0.030 |
Why?
|
Postmenopause | 1 | 2006 | 2519 | 0.030 |
Why?
|
Creatinine | 1 | 2022 | 1917 | 0.030 |
Why?
|
HLA Antigens | 1 | 2002 | 1336 | 0.030 |
Why?
|
Congenital Abnormalities | 1 | 2021 | 703 | 0.030 |
Why?
|
Pilot Projects | 2 | 2018 | 8742 | 0.030 |
Why?
|
Probability | 1 | 2002 | 2483 | 0.030 |
Why?
|
Ribonuclease H | 1 | 1996 | 52 | 0.030 |
Why?
|
Blood Transfusion | 1 | 2003 | 1309 | 0.030 |
Why?
|
Armenia | 1 | 2015 | 16 | 0.030 |
Why?
|
Neoplasms | 2 | 2016 | 22390 | 0.030 |
Why?
|
Databases, Genetic | 2 | 2014 | 1758 | 0.030 |
Why?
|
Age Distribution | 1 | 2002 | 2875 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2007 | 3518 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2004 | 4123 | 0.030 |
Why?
|
Cytochrome P-450 CYP1A1 | 1 | 2015 | 88 | 0.030 |
Why?
|
Sex Factors | 2 | 2015 | 10641 | 0.030 |
Why?
|
Aryldialkylphosphatase | 1 | 2015 | 64 | 0.030 |
Why?
|
DNA, Viral | 1 | 2002 | 2205 | 0.030 |
Why?
|
Nasopharynx | 1 | 2018 | 420 | 0.030 |
Why?
|
Breast Feeding | 1 | 2003 | 1364 | 0.030 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1996 | 706 | 0.030 |
Why?
|
Pluripotent Stem Cells | 1 | 2021 | 810 | 0.030 |
Why?
|
Dyspnea | 1 | 2022 | 1352 | 0.030 |
Why?
|
Rats | 2 | 2021 | 23847 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2022 | 81892 | 0.030 |
Why?
|
Data Interpretation, Statistical | 1 | 2004 | 2714 | 0.030 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2018 | 452 | 0.030 |
Why?
|
Mass Screening | 1 | 2010 | 5455 | 0.030 |
Why?
|
Diabetic Nephropathies | 1 | 2001 | 973 | 0.030 |
Why?
|
Leukotrienes | 1 | 2015 | 232 | 0.030 |
Why?
|
Diabetes Insipidus, Neurogenic | 1 | 2013 | 20 | 0.030 |
Why?
|
Ketosis | 1 | 2013 | 46 | 0.030 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2016 | 423 | 0.030 |
Why?
|
Agriculture | 1 | 2014 | 187 | 0.030 |
Why?
|
Multifactorial Inheritance | 1 | 2021 | 1423 | 0.030 |
Why?
|
Primary Prevention | 1 | 2020 | 1187 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2021 | 1890 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2016 | 13699 | 0.030 |
Why?
|
Workflow | 1 | 2017 | 859 | 0.030 |
Why?
|
Incidence | 3 | 2010 | 21545 | 0.030 |
Why?
|
Lumbar Vertebrae | 1 | 2022 | 1889 | 0.030 |
Why?
|
Morocco | 1 | 2012 | 36 | 0.030 |
Why?
|
Meta-Analysis as Topic | 1 | 2017 | 1364 | 0.020 |
Why?
|
Afghanistan | 1 | 2012 | 78 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2003 | 3724 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2021 | 2431 | 0.020 |
Why?
|
Asia, Central | 1 | 2011 | 13 | 0.020 |
Why?
|
Piperazines | 1 | 2003 | 2553 | 0.020 |
Why?
|
Vitamins | 1 | 2020 | 1638 | 0.020 |
Why?
|
Systems Biology | 1 | 2016 | 482 | 0.020 |
Why?
|
Software | 1 | 2006 | 4480 | 0.020 |
Why?
|
Asia, Southeastern | 1 | 2011 | 115 | 0.020 |
Why?
|
Health Surveys | 1 | 2002 | 4055 | 0.020 |
Why?
|
Markov Chains | 1 | 2015 | 979 | 0.020 |
Why?
|
Pregnancy | 3 | 2010 | 30175 | 0.020 |
Why?
|
Genome | 1 | 2019 | 1752 | 0.020 |
Why?
|
Lens, Crystalline | 1 | 2013 | 387 | 0.020 |
Why?
|
Organic Anion Transporters | 1 | 2012 | 101 | 0.020 |
Why?
|
Infectious Disease Transmission, Vertical | 2 | 2010 | 1360 | 0.020 |
Why?
|
Overweight | 1 | 2022 | 2445 | 0.020 |
Why?
|
Flucytosine | 1 | 2010 | 33 | 0.020 |
Why?
|
Renin-Angiotensin System | 1 | 2016 | 736 | 0.020 |
Why?
|
Coffee | 1 | 2015 | 594 | 0.020 |
Why?
|
Internationality | 1 | 2016 | 1008 | 0.020 |
Why?
|
Linguistics | 1 | 2011 | 110 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 1996 | 3056 | 0.020 |
Why?
|
Infant, Newborn | 3 | 2021 | 26394 | 0.020 |
Why?
|
Russia | 1 | 2011 | 386 | 0.020 |
Why?
|
DNA | 1 | 2004 | 7214 | 0.020 |
Why?
|
Pyrimidines | 1 | 2003 | 3050 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 2015 | 773 | 0.020 |
Why?
|
Lipids | 1 | 2021 | 3345 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2002 | 3335 | 0.020 |
Why?
|
Corneal Transplantation | 1 | 2013 | 315 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2002 | 3110 | 0.020 |
Why?
|
Protons | 1 | 2015 | 1113 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39394 | 0.020 |
Why?
|
Serotyping | 1 | 2010 | 332 | 0.020 |
Why?
|
Data Mining | 1 | 2014 | 563 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2017 | 2357 | 0.020 |
Why?
|
Fetal Membranes, Premature Rupture | 1 | 2010 | 137 | 0.020 |
Why?
|
Diuretics | 1 | 2012 | 614 | 0.020 |
Why?
|
Homeostasis | 1 | 2020 | 3348 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2005 | 15471 | 0.020 |
Why?
|
Obstetric Labor, Premature | 1 | 2010 | 266 | 0.020 |
Why?
|
Insulin | 1 | 2002 | 6610 | 0.020 |
Why?
|
Lentivirus | 1 | 2010 | 520 | 0.020 |
Why?
|
Pain | 1 | 2003 | 5100 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2021 | 7609 | 0.020 |
Why?
|
Genomics | 2 | 2015 | 5928 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 2013 | 1614 | 0.020 |
Why?
|
Acute Disease | 1 | 2018 | 7245 | 0.020 |
Why?
|
Virus Replication | 1 | 1995 | 2458 | 0.020 |
Why?
|
Prospective Studies | 2 | 2022 | 54950 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2010 | 2018 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2003 | 9549 | 0.020 |
Why?
|
Prostheses and Implants | 1 | 2013 | 1279 | 0.020 |
Why?
|
3' Untranslated Regions | 1 | 2008 | 515 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 2862 | 0.020 |
Why?
|
Coronary Vessels | 1 | 2017 | 3124 | 0.020 |
Why?
|
Time Factors | 3 | 2017 | 40266 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 2013 | 2001 | 0.020 |
Why?
|
Hematuria | 1 | 2006 | 233 | 0.020 |
Why?
|
Neonatal Screening | 1 | 2010 | 618 | 0.020 |
Why?
|
RNA | 1 | 1995 | 2727 | 0.020 |
Why?
|
Siblings | 1 | 2009 | 829 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2010 | 3588 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2015 | 3782 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 1996 | 13427 | 0.010 |
Why?
|
Mice, Nude | 1 | 2010 | 3631 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2020 | 10486 | 0.010 |
Why?
|
Gene Regulatory Networks | 1 | 2012 | 1752 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2021 | 11684 | 0.010 |
Why?
|
Diabetic Retinopathy | 1 | 2013 | 1299 | 0.010 |
Why?
|
Visual Acuity | 1 | 2013 | 2714 | 0.010 |
Why?
|
HIV Seronegativity | 1 | 2004 | 210 | 0.010 |
Why?
|
Gene Products, tax | 1 | 2003 | 51 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2010 | 21187 | 0.010 |
Why?
|
Computational Biology | 1 | 2015 | 3562 | 0.010 |
Why?
|
Internet | 1 | 2015 | 3112 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 3671 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8745 | 0.010 |
Why?
|
Frameshift Mutation | 1 | 2004 | 393 | 0.010 |
Why?
|
Blood Donors | 1 | 2004 | 344 | 0.010 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2003 | 183 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2003 | 11886 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2013 | 3450 | 0.010 |
Why?
|
Gestational Age | 1 | 2010 | 3610 | 0.010 |
Why?
|
Trisomy | 1 | 2003 | 260 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2017 | 19023 | 0.010 |
Why?
|
|